|0.802||-0.0181 / -2.21%|
As of 4:00pm ET
|0.78||-0.022 / -2.74%|
The 2 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +648.13% increase from the last price of 0.80.
The current consensus among 2 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.